ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 134 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2019. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $423,808 | +111.9% | 77,763 | +160.9% | 0.00% | – |
Q2 2023 | $200,005 | -65.4% | 29,807 | -54.5% | 0.00% | -100.0% |
Q1 2023 | $578,383 | +91.4% | 65,502 | +65.6% | 0.00% | – |
Q4 2022 | $302,154 | -99.9% | 39,549 | -53.0% | 0.00% | -100.0% |
Q3 2022 | $598,529,000 | +94.9% | 84,063 | +121.4% | 0.00% | – |
Q2 2022 | $307,161,000 | +160.8% | 37,968 | +347.5% | 0.00% | – |
Q1 2022 | $117,772,000 | +34.3% | 8,485 | +171.4% | 0.00% | – |
Q4 2021 | $87,716,000 | -17.4% | 3,126 | +0.1% | 0.00% | – |
Q3 2021 | $106,151,000 | +55.0% | 3,123 | +86.3% | 0.00% | – |
Q2 2021 | $68,481,000 | -48.9% | 1,676 | -49.7% | 0.00% | – |
Q1 2021 | $134,106,000 | -17.1% | 3,331 | +21.7% | 0.00% | – |
Q4 2020 | $161,839,000 | +182.0% | 2,737 | +131.9% | 0.00% | – |
Q3 2020 | $57,383,000 | -59.8% | 1,180 | -60.1% | 0.00% | – |
Q2 2020 | $142,915,000 | +218.7% | 2,954 | +83.0% | 0.00% | – |
Q1 2020 | $44,837,000 | +89.9% | 1,614 | +104.6% | 0.00% | – |
Q4 2019 | $23,607,000 | +14.0% | 789 | +17.8% | 0.00% | – |
Q3 2019 | $20,703,000 | – | 670 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |